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Executive Summary
Many discussions of managed care, as well as policy making and research ef-
forts, treat managed care with a broad brush, forcing a wide variety of organi-
zations into a single framework that facilitates discussion but abstracts from
a number of key issues. Although it may be instructive to conduct broad dis-
cussions about managed care, a more detailed understanding of the specific
activities that managed care plans undertake and their likely effects is re-
quired to support comprehensive policy efforts. Frequently, however, efforts to
be more detailed are hampered by shortcomings in the measurement of man-
aged care.
This paper lays out a framework of the various activities undertaken by
managed care organizations that may be helpful in developing further efforts
to understand and measure specific plan activities. The paper also discusses
and evaluates some common measures. Detailed data on the exact activities
of health insurers and managed care plans are not widely available. One
commonly used, but less detailed, measure is the percent of the population
enrolled in health maintenance organizations (HMOs). Another places markets
on a continuum based on the estimated stage of managed care development
in the market. Using data from a new survey, this article compares available
measures with more detailed data, suggesting that available data on 1-IMO
market share seems to accurately reflect HMO activity, but may not capture
the prevalence of some underlying activities of plans like having strong re-
strictions on enrollee choice of providers, and may also not capture the
prevalence of other forms of managed care plans (e.g. Preferred Provider
Organizations).
These results suggest the importance of distinguishing between the many ac-
tivities of managed care plans when considering policies that would influence
the development of managed care, and when evaluating results from research
studies that primarily rely on measures of HMO activity. Results from studies
of HMOs may not apply to other types of managed care plans. Policies that tar-
get HMOs, or other managed care plans broadly, may be less effective than pol-
icies that target specific activities of plans.92 Baker
I.Introduction
As managed care has grown in prominence, numerous research efforts
and policy discussions have considered its effects on the health care
system and health care delivery. Many of these efforts have treated
managed care with a broad brush, however, forcing a wide variety of
organizations into a single framework that facilitates discussion but
abstracts from several key issues. A central goal of managed care is
containing the costs of delivering care, but the wide variety of organi-
zations typically lumped together under the umbrella of managed care
pursue this goal using combinations of numerous strategies that vary
from market to market and from organization to organization. In most
cases, these specific strategies and activities will determine theeffects
of organizations on matters of interest like costs, patient and physician
satisfaction, and health outcomes. Although it may be instructive to
conduct broad discussions about managed care on some occasions, a
more detailed understanding of the specific activities that plans can
undertake and their likely effects is required to support comprehensive
research and policy efforts. One goal of this article is to begin laying out
a framework of the various activities undertaken by managed care or-
ganizations that may be helpful in developing additional efforts to un-
derstand and measure specific plan activities.
A second goal is to examine available measures of managed care ac-
tivity. While it would be useful and interesting to have detailed data on
the exact activities of health insurers and managed care plans, such
data are not widely available. Rather, researchers and policy makers
have frequently been forced to use less detailed measures in the im-
plicit hope that they serve as adequate proxies for the use of various
cost containment strategies. One commonly used measure is the per-
centage of the population enrolled in health maintenance organizations
(HMOs). Good data on the number of HMOs operating and HMO en-
rollment in different types of the country are relatively easy to obtain,
and many health care data sets contain indicators for patients who are
enrolled in HMOs. Another common measure places markets on a con-
tinuum based on the estimated stage of managed care development in
the market.
While they have often been the only feasible alternatives, these mea-
sures have some important drawbacks. One is that it is not clear how
accurate even these broad measures are. Available measures of marketWhat Does HMO Market Share Measure? 93
share are based on estimation algorithms that are difficult to validate
and have not been widely compared against other data sources. In ad-
dition, HMO market share and managed care staging may or may not
adequately capture variations in the use of specific cost containment
strategies, and the extent to which they do has not been examined. A
better understanding of the quality of available HMO market share
and market staging data, and the relationship among HMO market
share, market staging, and specific plan activities could help focus
the interpretation of studies of the effects of managed care and guide
policy-making efforts.
This article reports results from analyses of some recent household
survey data from the Center for Studying Health Systems Change that
provide additional information on managed care activity at the market
level, including both broad measures of HMO market share and more
detailed measures of the use of various restrictions on provider
choices, one type of cost containment activity in which health plans can
engage. The analyses examine three issues. First, I compare existing
measures of HMO market share and stage of managed care develop-
ment with data on HMO market share available from the survey in an
effort to examine the validity of the various existing measures of HMO
market share. Second, I examine the correspondence between broad
measures of managed care activity, namely, HMO market share and
market staging measures, and the presence of various limitations that
plans place on provider choice. Finally, I examine the impact that using
more detailed measures of plan activities, rather than broader mea-
sures like HMO market share, could have on the results of studies.
II.Cost Containment Activities of Health Plans
The most useful measurements of managed care activity would contain
data on the specific activities in which plans engage. Managed care
plans can pursue cost containment through a wide variety of activities
that can be loosely grouped into five categories. First, health plans
may define networks of physicians and health care providers with
whom they will work. Defining a panel offers managed care plans the
advantage of selecting providers with whom they are interested in
working as well as the potential to obtain some contracting advantages
through which they can sometimes obtain discounts from physicians
who would like to be included in the panel. Some plans define rela-94 Baker
tively broad networks of affiliated physicians and providers, while
other plans focus their efforts on building a relatively narrow panel
and carefully managing it to include only those providers whose pat-
terns of practice are most consistent with the plan's goals.
Second, many plans impose restrictions on patient choices of provid-
ers. Plans that have formed networks can impose varying degrees of
control on the ability of patients to choose providers in and out of the
network. Some plans will not pay for care delivered by physicians not
included in the approved panel. Other plans simply provide some
financial incentives for patients to see physicians on the plan's panel,
but they do pay at least part of the bill for out-of-network care. Many
plans also regulate the use of specialists, for example, by forcing pa-
tients to sign up with a particular primary care physician or group of
physicians and then to obtain a referral from this "gatekeeper" physi-
cian or group when specialized services are required.
Third, plans can impose direct controls on utilization. For example,
patients and their physicians may be forced to obtain preapproval from
a utilization review organization for diagnostic tests, surgical proce-
dures, and other services, if the plan is to pay for the services. Plans can
then deny approval for services that they deem to be inappropriate
uses of resources. In some cases, direct utilization controls can be im-
posed in an interactive process with providers. In others, plans simply
identify approved and disapproved treatments. For example, many
plans have developed detailed formulas of approved pharmaceutical
products for which they will pay, effectively limiting prescribing to the
approved list.
Fourth, plans can impose indirect controls on utilization by using
financial arrangements that put providers at risk for the financial im-
plications of the patient care decisions they make. For example, many
plans use capitation contracts in which physician groups are paid a
fixed amount per member per month to care for the patients who have
signed up with them. In other cases, plans may withhold a portion of
the payments due to physicians and reallocate these funds at the end of
the year based on the performance of physicians or groups in meeting
utilization, quality or other targets imposed by the plans. These kinds
of incentives may lead physicians to limit utilization without the use of
direct central management of utilization.
Finally, many plans engage in efforts to influence physician practice
patterns by changing physician opinions about the best ways to careWhat Does HMO Market Share Measure? 95
for their patients. For example, they may provide information, promul-
gate guidelines, and define standards for care. Plans may also influence
practice patterns by collecting data on the performance of services that
the plan (or other observers like the National Center for Quality Assur-
ance) believe to be indicators of quality or of excessive resource use.
Most health plans use more than one of these techniques, and plans
vary widely in the combinations of approaches they use and in the
weight that they put on each approach. Ideally, measurement efforts
would collect data on each type of plan activity. This technique has
been difficult but is becoming more feasible over time with emerging
databases. Tightness of networks may be identifiable from HMO-level
data on the number of physicians in the plans. Restrictions on patient
choices are identifiable in some new surveys like the Medical Expendi-
hire Panel Survey (MEPS) and the Community Tracking Study Sur-
veys. Information about the use of capitation appears identifiable from
physician surveys.
If the specific activities of plans are not fully measurable, an alternate
strategy of pursuing data on a wide variety of health plan model types
is also increasingly feasible and should present an improvement over
existing HMO market share and market staging measures. To some ex-
tent, different combinations of approaches define the stereotypical ver-
sion of the organizational forms that are commonly observed in the
marketplace. Thus, if one can measure the market shares of different
kinds of health plans, a significant amount of information about the
underlying activities of plans is likely to be gained. Staff and group
model HMOs, like Kaiser Permanente, tend to define narrowly a net-
work of providers whose financial incentives are closely aligned with
the incentives of the plans and to restrict patients to choosing only pro-
viders in the network. Because the panels are carefully defined and
financial incentives are already integrated, there is relatively little need
to impose strong central controls on utilization or use financial incen-
tives to limit costs. Staff and group HMOs often work hard to define
practice guidelines for their physicians.
IPA model HMOs typically have more loosely defined networks of
physicians and restrict patients to staying within the network. The
looseness of the network and the lack of integration with the plan re-
quires stronger efforts to contain utilization. IPA model HMOs vary in
the emphasis they place on using financial incentives as opposed to di-
rect controls, but the prototypical IPA model HMO relies heavily on96 Baker
some combination of the two. Preferred provider organizations (PPOs)
are characterized by relatively loose panels, some incentives to choose
providers in the network (but weaker incentives than those used by
HMOs), and limited efforts to control utilization. As a result, PPOs
have been regarded as potentially less effective at controlling costs than
other organizations. Many formerly unmanaged indemnity plans have
also adopted managed care techniques in past years, typically consist-
ing of efforts to impose some (often limited) central control on utiliza-
tion patterns.
Regardless of how it is measured, obtaining additional information
about the prevalence and impact of specific aspects of health plan ac-
tivities is needed. Different approaches may have different effects on
the health care system. Some of these approaches may be more effec-
tive at controlling utilization and costs than others. Some may drive
physician and patient dissatisfaction more than others. Some may be
more or less effective at fostering truly high-quality health care deliv-
ery. Identifying strategies that promote the best blend of strategies is an
important policy goal. The remainder of this article discusses the meas-
urement of managed care using some new survey data.
III.Household Survey Data
In late 1996 and early 1997, the Community Tracking Study Household
Survey (hereinafter the CTS) from the Center for Studying Health
Systems Change contacted households to inquire about the characteris-
tics of their health insurance. The CTS focused on sixty markets and
supplemented the sixty markets with a smaller nationwide sample. In
all, data on 60,446 individuals are available. I use data on those individ-
uals residing in one of the sixty focus markets, for a total of 56,798
individuals.
For each household surveyed, data were obtained about insurance
coverage for each adult and one of the children if children were pres-
ent. For each insured individual, the survey asked a series of questions
about his or her coverage that can be used to assess exposure to "man-
aged care" and about individual perceptions of the limitations placed
on choice of providers.1 These questions include:
1. "Does the plan require members to sign up with a certain primary
care doctor, group of doctors, or clinic, which they must go to for all of
their routine care?"What Does HMO Market Share Measure? 97
"Do members need approval or a referral to see a specialist or get
special care?"
"Is there a book, directory, or list of doctors associated with the
plan?" or, for patients with Medicaid, Medicare, or other state insur-
ance, "Can you go to any doctor or clinic who will accept
(Medicare/Medicaid/state plan) or must you choose from a book, di-
rectory or list of doctors?
"Is the plan an HMO, that is, a health maintenance organization?"
For people in plans with lists or in HMOs, the survey asked, "If
members do not have a referral, will the plan pay for any of the costs of
visits to doctors who are not associated with the plan/part of the
HMO?"
Using questions 1, 2, 3, and 5, I computed a variable that indicates the
presence of all of the possible restrictions ("very restrictive plan") and a
variable that indicates the presence of one or more of the restrictions
but not all of the restrictions ("somewhat restrictive plan").
Responses to these questions reflect individuals' perceptions of the
characteristics of their plans. Respondents may or may not be fully
knowledgeable about the detailed characteristics of their plans. The
Community Tracking Study does contain efforts to obtain additional
information about the plans from alternate sources, like the written
materials provided by each plan. Some preliminary analyses on these
materials suggest that responses to the question about whether the
plan is an HMO or not tend to be relatively accurate. But responses to
the other questions about restrictions are less likely to be accurate.
These analyses suggest the importance of viewing the data on plan re-
strictiveness as reflecting patient perceptions rather than necessarily
the actual characteristics of plans.
Some analyses are conducted at the individual level; others are at the
market level. The sixty markets targeted by the CTS include fifty-one
metropolitan statistical areas (MSAs) and nine other non-MSA market
areas. Sample sizes vary across the sites surveyed. Twelve of the sites
are "high density" sites and contain relatively large samples, and the
remaining forty-eight sites contain smaller samples. The minimum
market sample size for analyses using all individuals is 445 individu-
als. For the market level analysis, I computed market-level measures of
the percentage of respondents who reported being enrolled in an HMO98 Baker
and the percentage who report having the various restrictions on pro-
vider choice for each of the market areas represented in the CTS.2
IV.Comparing Existing Managed Care Measures to CTS Data
Interstudy Data and Market Staging
Existing studies of the effects of managed care have frequently used
measures of HMO market share based on surveys of HMOs, or market
staging data, but the accuracy of these data have not been carefully as-
sessed. This section compares these measures to data on HMO market
share obtained from the CTS. While the CTS data are themselves esti-
mates, observing a strong correspondence between existing data and
CTS data, which are derived from different methodologies, would sup-
port the view that both existing measures and CTS measures assess
HMO market share accurately.
A commonly used measure of HMO market share comes from the
Interstudy Competitive Edge Regional Market Analysis, which reports esti-
mates of the number of individuals enrolled in HMOs in many MSAs
(Interstudy 1997). These estimates are derived from HMO reports of
the number of their enrollees and the market area that they serve. To
obtain estimates for the MSAs, Interstudy apportions the enrollees
among the MSAs in the HMO's market area using data on area popula-
tions and HMO reports about the distribution of their enrollment
across MSAs. These measures are similar to measures that have been
used in the past by other researchers (e.g., Baker 1997, 1999, and
Wholey et al. 1997).
It was possible to link 1996 HMO market share estimates from the
Interstudy Competitive Edge Regional Market Analysis, version 7.1, to CTS
HMO market share estimates for fifty markets.3 Figure 4.1 plots the re-
lationship between Interstudy and CTS estimates. The Interstudy esti-
mates and estimates from the CTS survey are well correlated (r = 0.82),
but the Interstudy estimates are systematically higher. The mean
Interstudy market share is 41 percent, while the mean CTS market
share is 29 percent, and most of the observations in the figure are above
the 45 degree line. A regression of CTS market share on Interstudy mar-
ket share yields C = 23.11 + 0.60 * J, with p < 0.001 for both coefficients
and R2 of 0.68. More people report being in HMOs than are accounted
for in HMO market share estimates based on HMO surveys. Given the
accuracy of reporting of HMO enrollment apparent from the CTS fol-






Relationship between 1996 Interstudy HMO market share estimates and 1996 market
share estimates from the CTS household survey.
Note: N = 50 MSA markets. Bivariate OLS regression line shown.
understate HMO enrollment in some urban areas. From a research
standpoint, the high correlation suggests that both estimates should
produce similar qualitative results, perhaps subject to differences in the
scale of the coefficients obtained.
Market staging data attempt to assign markets to groups based on
the degree of development of managed care in the market. One such
measure is developed by the University HealthSystems Consortium
(UHC). For various markets, they compile information on a range of
market characteristics, including, for example, HMO market share, the
number of HMOs with more than 100,000 members, hospital occu-
pancy, hospital days per 1,000 members, number of hospital beds in
systems, and the number of state employees in HMOs. The specific
pieces of information included vary from year to year. Based on these
data, they assign markets a score between 1 and 4, with 4 representing
higher levels of managed care development.
Market staging data have some important drawbacks for research
(Burns et al. 1997). The methods used to stage markets are ad hoc and
can be hard to discern. Because they incorporate a wide range of infor-
mation into the staging calculation, there is a risk that the dependent
variables in some analyses may be included among the determinants of
the staging data. The algorithms and data used to define the stages can
0 20 40 60 80
















Relationship between 1996 UHC market stage estimate and 1996 market share estimates
from the CTS household survey
Note: N = 31 MSA markets. Bivariate OLS regression line shown.
also change over time, making it difficult to do time series work with
staging estimates. Nonetheless, some researchers have used staging
data in their analyses, and assessing their relationship with HMO mar-
ket share data and with the presence of restrictions on provider choice
seems useful.
Figure 4.2 plots the relationship between CTS HMO market share es-
timates and UHC's staging data from 1996 for thirty-one markets in
which there are both CTS and UHC data. As above, the two measures
are positively correlated (r = 0.70), and a regression of CTS market
share on stage yields C = 17.16 + 10.85 * U, with p < 0.01 for both
coefficients and R2 = 0.49. The positive correlation is not surprising be-
cause the UHC market staging data incorporate HMO market share es-
timates. The fact that the R2 value is lower here than it is with the
Interstudy data indicates a less tight relationship.
Medicare HMO Market Share
The value of comparisons with the CTS HMO market share data in-
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Figure 4.3
Relationship between 1996 HCFA Medicare HMO market share estimates and 1996
Medicare HMO market share estimates from the CTS household survey
Note: N = 51 MSA markets. Bivariate OLS regression line shown.
the accuracy of self-reported HMO membership in the CTS survey is to
compare CTS survey data for Medicare enrollees to Health Care Fi-
nancing Administration (HCFA) data on Medicare HMO enrollment.
Because it administers payments for managed care plans, HCFA keeps
accurate accounts of the number of Medicare beneficiaries enrolled in
HMOs, and thus the HCFA data provide useful benchmarks against
which CTS survey data can be compared.
Figure 4.3 plots Medicare HMO market share against CTS HMO
market share for Medicare enrollees. The average market shares across
the fifty-one markets are about the same: 18.2 percent in the HCFA
data, 20.1 percent in the CTS data. Some discrepancy is understandable
because there are several markets in which relatively few Medicare
beneficiaries were surveyed by the CTS, and hence some measurement
error is to be expected.4 The correlation between the two measures is
0.91. A regression of HCFA Medicare market share on CTS Medicare
market share yields C = 5.32 + 0.81 H, with p < 0.001 on both
coefficients and R2 = 0.83. This result is consistent with the view that
















Before extrapolating this finding to non-Medicare populations, how-
ever, one should remember that the accuracy of survey responses by
Medicare HMO enrollees, who face a clear choice between joining an
HMO and staying in FFS Medicare, may be higher than the accuracy of
responses among privately insured individuals who are confronted
with a set of insurance choices that are often not as well delineated.
V.Correspondence Between HMO Enrollment and Restrictions on
Provider Choice
Two important cost containment activities that plans can engage in are
defining networks of providers and creating policies that restrict pa-
tient choices of providers. This section examines the relationship be-
tween broad managed care measures and the presence of these types of
restrictions, which for ease of discussion I jointly term "provider choice
restrictions." First, I examine the relationship between an individual re-
porting that he or she has joined an HMO and responses to questions
about restrictions on provider choice using individual level data. Sec-
ond, I assess the relationship between area-level measures of HMO
market share and the restrictiveness of health plans.
Individual-Level Survey Data
Table 4.1 reports results from individual-level comparisons between in-
dicating HMO membership and indicating the presence of various re-
strictions on provider choice. The left-hand side of the table reports
results for all respondents. Responses to the HMO enrollment question
provide information about the perceived presence of restrictions on
provider choice. For each of the individual provider restrictions exam-
ined, between 70 and 80 percent of respondents fall on the diagonal
of the 2 X 2 matrix classifying indicated HMO membership and indi-
cated presence of restrictions. In all four cases, the majority of the
off-diagonal respondents are those who said that they were not in an
HMO but who did indicate the presence of a restriction. This is under-
standable given the number of non-HMO managed care organizations
that use various restrictions. It also suggests that reporting that one is a
member of an HMO is a good indicator that one does perceive the pres-
ence of restrictions on provider choice.
The last three rows show the correspondence between indicating















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































"somewhat restrictive," or "non-restrictive" plan. The relationships
here are not as clear. Perhaps the clearest lesson that can be drawn is
that an indication of not being a member of an HMO is a strong predic-
tor that an individual does not perceive him- or herself to be in a very
restrictive plan. Conversely, indicating HMO enrollment is a strong
predictor of perceiving that there are at least some restrictions on pro-
vider choice.
The right-hand side of the table repeats the analyses using only
Medicare enrollees, who may have a better grasp of whether or not
they are actually enrolled in an HMO. Here, results are similar but with
even stronger relationships between indicating HMO enrollment and
the presence of restrictions. Medicare beneficiaries face many fewer
choices of non-HMO organizations than those covered outside
Medicare, which may explain some of the difference.
It is interesting to note that a nontrivial number of traditional
Medicare beneficiaries (not enrolled in HMOs) indicated that they had
a gatekeeper and that they had to sign up with a primary care provider.
These reports suggest that there are differences between perceived and
real restrictions on provider choice because the traditional Medicare
program does not require gatekeepers or signing up with a primary
care physician. Overall, these results do suggest that individual-level
data on HMO enrollment in studies will provide some useful informa-
tion about the perceived presence of restrictions on provider choice, al-
though it may not fully capture variation in this dimension.
Market-Area Data
Many studies examine market-level data instead of individual level
data. Aggregated, market-level relationships between HMO enroll-
ment and the presence of provider choice restrictions may differ from
the individual-level relationships discussed above. To examine this dif-
ference, I compared the market-level measures of HMO market share
and provider choice restrictions from the CTS. I also compared CTS
provider choice restriction data to Interstudy HMO measures, UHC
market staging data, and HCFA data on HMO market share for
Medicare beneficiaries.
Figures 4.4 through 4.6 graph the relationships between CTS HMO
market share and the percentage of the population who indicate being
in a very restrictive, somewhat restrictive, and nonrestrictive plan, re-40 -
20 -
0-
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Figure 4.4
Relationship between CTS HMO market share estimates and CTS estimate of percentage
of population in a very restrictive plan
Note: N = 60 CTS markets. Bivariate OLS regression line shown.
spectively. Market-level means of the various provider choice restric-
tions and their correlations with CTS, Interstudy, UHC, andHCFA
measures of managed care activity are shown in table4.2 for all pa-
tients on the left and Medicare patients on the right.
HMO market share estimates from CTS and Interstudy are very posi-
tively correlated with the percentage of the population who say that
they are enrolled in very restrictive plans, and very negatively corre-
lated with the percentage of the population who say that they are en-
rolled in nonrestrictive plans. There is not a strong relationship
between HMO market share and the percentage of the population in
somewhat restrictive plans. The relationship between UHC market
staging measures and provider choice restrictions is generally weaker.
Staging measures are also correlated with both very restrictive and
somewhat restrictive plans. For Medicare patients, where the HMO
and provider choice restriction data is probably better, the observed
correlations are stronger.
Overall, these results suggest that market level measures of HMO
market share are likely to reflect underlying perceptions of the pres-
ence of strong restrictions on provider choicebut may not capture as
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Figure 4.5
Relationship between CTS HMO market share estimates and CTS estimate of percentage
of population in a somewhat restrictive plan
Note: N = 60 CTS markets. Bivariate OLS regression line shown.
sures like those from the UHC may not do as good a job of capturing
the presence of provider choice restrictions as HMO market share
measures.
VI.Implications of Using HMO Market Share in Market Studies
A key question for research and policy concerns the implications of re-
sults from research studies that use different measures of managed care
activity. Many studies have examined the effects of managed care on
health expenditures (e.g., Baker 1999), on technology adoption (e.g.,
Cutler and Sheiner 1998), and other aspects of the health care delivery
system, relying on measures of HMO market share. At a deeper level,
however, the hypotheses that drive these studies derive from various
specific activities of health plans, like the strength of network arrange-
ments, the use of provider choice restrictions, and the use of capitation,
not from HMO market share per Se. Thus, a better understanding of the
extent to which HMO market share and other measures of managed
care activity are related to the underlying activities of health plans can
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Figure 4.6
Relationship between CTS HMO market share estimates and CTS estimate of percentage
of population in a nonrestrictive plan
Note: N = 60 CTS markets. Bivariate OLS regression line shown.
Results presented above suggest that various measures of HMO
market share should produce similar results, and that HMO market
share should do a reasonable job of reflecting the perceived presence of
various provider choice restrictions. However, HMO market share was
correlated most closely with the perception that plans were "very re-
strictive" but not with the perception that plans were "somewhat re-
strictive." Thus, results from studies of HMO market share may be best
interpreted as reflecting the effects of having very restrictive rather
than somewhat restrictive plans in the area.
To illustrate, this section revisits a previous study of the effects of
managed care on the availability of MRI. Baker and Wheeler (1998)
summarize some results from a project designed to investigate the rela-
tionship between HMO market share and the availability of MRI units
in the mid-1990s. Their article used cross-sectional regressions in which
the dependent variable measured the number of Mmachines per
capita in market areas and the key independent variable was the HMO
market share in the area. Other controls for demographics, rural and
urban areas, and the like, were also included. The main finding was
that increases in HMO activity are statistically significantly associated
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Here, I repeat some of the earlier models with new measures of man-
aged care and the presence of provider choice restrictions. From the
original data set, I extracted data on the fifty-one MSA market areas in-
cluded in the CTS data set, and estimated models in which the various
CTS measures of provider choice restrictions (in the entire population)
are used to explain the number of Mifi sites per 100,000populations in
1995. None of the estimated coefficients are statistically significant, per-
haps because of the very small sample size. Nonetheless, the results do
illustrate the variations in results that can be associated with using dif-
ferent measures.
Results are summarized in table 4.3. Using the 1994 HMO market
share measure used in the original study, the coefficient point estimates
suggest that increases in HMO market share are associated with reduc-
tions in Mifi availability. Similar results are obtained when the percent-
age of individuals enrolled in HMOs in 1996 from theCTS is used.
When the percentages of the population in very restrictive and some-
what restrictive plans are used, the results suggest that increases in the
percentage in very restrictive plans is associated with declines in MRI
availability, but the percentage in somewhat restrictive plans is not as-
sociated with changes in MRI availability. The percentage of patients
who have a gatekeeper and the percentage of patients who have to sign
up with a primary care physician or group haverelatively large nega-
tive correlations with the number of MRIs, but the percentage of pa-
tients who have to choose from a list of providers has a small positive
coefficient.
This analysis is not intended to serve as a careful study of MRI avail-
ability but to illustrate the implications of better measurement of man-
aged care activity. Without detailed data, one might be tempted to
extrapolate from just HMO market share to conclude that the presence
of "managed care" reduced MRI availability more generally. But the
more detailed data suggest that the HMOeffect observed is associated
most closely with very restrictive plans with multiple restrictions,with
the presence of gatekeepers, and with the requirement that individuals
sign up with primary care physicians. Stereotyping plans, this evi-
dence might suggest that HMOs, but not looser organizational forms
like PPOs, are associated with reductions in MRI availability. If one
were thinking of targeting regulatory or policyefforts at managed care
with the intention of influencing technology diffusion, distinctions
between organizations and/or the specific managed care activities may
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physician satisfaction, health care costs, health outcomes, and other is-
sues of interest.
VII.Conclusions
Comparisons of data from various sources suggest that some existing
measures of HMO market share are well correlated with new sur-
vey-based measures of HMO activity and that HMO market share
does convey a significant amount of information about the presence of
restrictions on provider choice, particularly the presence of the set of
provider choice restrictions that here define very restrictive plans. Re-
search results that use HMO market share are thus likely to reflect the
effects of more and more stringent restrictions on provider choice
rather than the presence of just a few, less stringent restrictions.
Market staging measures are also used in some studies. Here, these
measures were correlated with HMO market share measures and with
the presence of provider choice restrictions. The relationship is weaker,
however, which leave results from studies using market staging per-
haps less easy to interpret as indicators of the presence of provider
choice restrictions.
Although many discussions have focused on measures of HMO mar-
ket share, making finer distinctions between health plans based on the
kinds of activities they undertake could help target policy-making ac-
tivities more accurately. Different health plan activities may have dif-
ferent effects on satisfaction, costs, quality, and other aspects of plan
performance, and may be influenced best by specifically targeted poi-
icy interventions. The data needed to support studies of the activities
of plans has been sparse but are becoming more easily available and
should be explored.
Notes
Prepared for the Third Annual NBER Frontiers in Health Policy Research conference,
Washington DC, June 17, 1999.
I am grateful for the excellent assistance of Michael Knisley and Nadia Kapp. This work
was supported by a grant from the Robert Wood Johnson Foundation Health Care Fi-
nancing and Organization (HCFO) program.
1. For persons in families with private insurance, the survey asked about up to three pri-
vate plans, and I included information from all three plans if present. For example, an in-
dividual enrolled in three plans is considered to be enrolled in an HMO if he or she indi-
cated that any of the three plans was an HMO. In the data, 84.5 percent of respondents
have one plan, 14.7 percent have two plans, and 0.8 percent have three plans.112 Baker
The site-level measures are weighted to adjust for sampling patterns and nonresponse
within each site.
Nine of the sixty CTS markets consisted of groups of counties that did not constitute
an MSA and hence could not be linked to the Interstudy data. In one case (Dothan),
Interstudy did not report an estimate, so I use fifty observations for this comparison.
Since the Interstudy data include everyone in the market, the CTS measures used here
reflect 1-IMO enrollment and provider choice restrictions for everyone in the CTS survey.
The minimum number of observations per market data set is 45. The number of obser-
vations in the median market is 86. The correlation between CTS and HCFA data using
only the 33 markets with at least 75 observations is 0.94.
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